185 related articles for article (PubMed ID: 19073973)
1. Screening for prostate cancer among men 75 years of age or older.
Barry MJ
N Engl J Med; 2008 Dec; 359(24):2515-6. PubMed ID: 19073973
[No Abstract] [Full Text] [Related]
2. Prostate cancer screening in men 75 years old or older: an assessment of self-reported health status and life expectancy.
Hoffman KE; Nguyen PL; Ng AK; D'Amico AV
J Urol; 2010 May; 183(5):1798-802. PubMed ID: 20299039
[TBL] [Abstract][Full Text] [Related]
3. Comment on the US Preventive Services Task Force's draft recommendation on screening for prostate cancer.
Kwiatkowski M; Klotz L; Hugosson J; Recker F
Eur Urol; 2012 Apr; 61(4):851-4. PubMed ID: 22285762
[No Abstract] [Full Text] [Related]
4. Stratifying risk--the U.S. Preventive Services Task Force and prostate-cancer screening.
Schröder FH
N Engl J Med; 2011 Nov; 365(21):1953-5. PubMed ID: 22029756
[No Abstract] [Full Text] [Related]
5. Re: Prostate cancer screening in men 75 years old or older: an assessment of self-reported health status and life expectancy. K. E. Hoffman, P. L. Nguyen, A. K. Ng and A. V. D'Amico. J Urol 2010; 183: 1798-1802.
Neulander EZ
J Urol; 2011 May; 185(5):1982; author reply 1983. PubMed ID: 21421243
[No Abstract] [Full Text] [Related]
6. Prostate-cancer screening--what the U.S. Preventive Services Task Force left out.
Brett AS; Ablin RJ
N Engl J Med; 2011 Nov; 365(21):1949-51. PubMed ID: 22029759
[No Abstract] [Full Text] [Related]
7. One man at a time--resolving the PSA controversy.
McNaughton-Collins MF; Barry MJ
N Engl J Med; 2011 Nov; 365(21):1951-3. PubMed ID: 22029758
[No Abstract] [Full Text] [Related]
8. How can rates of prostate-specific antigen screening be reduced in men aged 80 and older?
Whittle J; Zablocki CJ
J Am Geriatr Soc; 2010 Apr; 58(4):757-9. PubMed ID: 20398158
[No Abstract] [Full Text] [Related]
9. [The National Board of Health and Welfare's guidelines for prostatic cancer care. PSA test screening--only for well-informed men].
Bratt O; Damber JE; Kärvinge C; Malm T; Hensjö LO; Hyttsten E
Lakartidningen; 2008 Feb 20-26; 105(8):524-8. PubMed ID: 18363292
[No Abstract] [Full Text] [Related]
10. Prostate cancer. When to offer screening in the primary care setting.
Gambert SR
Geriatrics; 2001 Jan; 56(1):22-6, 29-31. PubMed ID: 11196336
[TBL] [Abstract][Full Text] [Related]
11. Early detection of prostate cancer. Role of prostate-specific antigen.
Prabhakaran VM
Can Fam Physician; 1996 Apr; 42():709-12. PubMed ID: 8653039
[TBL] [Abstract][Full Text] [Related]
12. Randomized trial results did not resolve controversies surrounding prostate cancer screening.
Hoffman RM
Curr Opin Urol; 2010 May; 20(3):189-93. PubMed ID: 20224414
[TBL] [Abstract][Full Text] [Related]
13. Estimation of treatment benefits when PSA screening for prostate cancer is discontinued at different ages.
Ross KS; Guess HA; Carter HB
Urology; 2005 Nov; 66(5):1038-42. PubMed ID: 16286120
[TBL] [Abstract][Full Text] [Related]
14. Guideline update: what's the best approach for screening asymptomatic men for prostate cancer?
Holten KB; Al-Abdulla S
J Fam Pract; 2009 Dec; 58(12):E2. PubMed ID: 19961813
[TBL] [Abstract][Full Text] [Related]
15. [Mass screening for prostate cancer is the best approach to early diagnosis and treatment of prostate cancer].
Zhao XJ; Kong XB; Wang WH
Zhonghua Nan Ke Xue; 2003 Nov; 9(8):563-5, 568. PubMed ID: 14689882
[TBL] [Abstract][Full Text] [Related]
16. Prostate cancer in older men.
Calabrese DA
Urol Nurs; 2004 Aug; 24(4):258-64, 268; quiz 269. PubMed ID: 15446376
[TBL] [Abstract][Full Text] [Related]
17. Prostate-specific antigen levels in the United States: implications of various definitions for abnormal.
Welch HG; Schwartz LM; Woloshin S
J Natl Cancer Inst; 2005 Aug; 97(15):1132-7. PubMed ID: 16077071
[TBL] [Abstract][Full Text] [Related]
18. Prostate-specific antigen-based screening for prostate cancer: evidence, controversies and future perspectives.
Ito K
Int J Urol; 2009 May; 16(5):458-64. PubMed ID: 19341365
[TBL] [Abstract][Full Text] [Related]
19. Controversies in prostate cancer screening and treatment.
Gaines KK
Urol Nurs; 2010; 30(3):165-6. PubMed ID: 20648853
[No Abstract] [Full Text] [Related]
20. Practitioner-level determinants of inappropriate prostate-specific antigen screening.
Kerfoot BP; Holmberg EF; Lawler EV; Krupat E; Conlin PR
Arch Intern Med; 2007 Jul; 167(13):1367-72. PubMed ID: 17620529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
